N
QCOR

Nuveen’s QUESTCOR PHARMA INC QCOR Stock Holding History

Nuveen’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-4,323
Closed -$281K – 1684
2014
Q1 		$281K Hold
4,323
– – ﹤0.01% 1443
2013
Q4 		$235K Sell
4,323
-186,189
-98% -$11M ﹤0.01% 1464
2013
Q3 		$11.1M Buy
+190,512
New +$11.3M 0.07% 334

Other funds holding QCOR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nuveen's QCOR Position: Q2 2014 in Review

Nuveen sold out of QUESTCOR PHARMA INC (QCOR) in Q2 2014, closing a stake of 4,323 shares — an estimated $281K sold.

Nuveen first reported a position in QCOR in Q3 2013 and held it in 3 quarters. The position peaked at $11.1M in Q3 2013. 320 funds tracked by Wall St. Rank hold QCOR as of Q2 2014.

  • Nuveen reported no remaining QUESTCOR PHARMA INC position as of Q2 2014 after selling out during the quarter.
  • Nuveen sold 4,323 QUESTCOR PHARMA INC shares in Q2 2014, an estimated $281K.
  • Nuveen first reported a position in QUESTCOR PHARMA INC in Q3 2013 and held it in 3 quarters.
  • Nuveen's QUESTCOR PHARMA INC position peaked at $11.1M in Q3 2013.
  • 320 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q2 2014.

Based on Nuveen's 13F filing for Q2 2014, filed 14 Aug 2014.